XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) - USD ($)
$ in Thousands
Total
Redeemable Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance at Dec. 31, 2020 $ (20,319)         $ (20,319)
Redeemable convertible preferred stock, Beginning balance at Dec. 31, 2020   $ 23,070        
Redeemable convertible preferred stock, beginning balance, shares at Dec. 31, 2020   6,076,196        
Beginning balance, shares at Dec. 31, 2020     2,707,468      
Redeemable convertible preferred stock, Accretion to redemption value and cumulative dividends on preferred stock   $ 761        
Accretion to redemption value and cumulative dividends on preferred stock (761)     $ (14)   (747)
Issuance of Series B redeemable convertible preferred stock at $15 per share for cash, net of issuance costs of $266   $ 79,734        
Issuance of Series B redeemable convertible preferred stock at $15 per share for cash, net of issuance costs of $266, shares   5,333,292        
Issuance of common stock upon the exercise of stock options, shares     22,830      
Vesting of early exercised stock options 6     6    
Stock-based compensation 8     8    
Net loss (2,048)         (2,048)
Ending balances at Mar. 31, 2021 (23,114)         (23,114)
Redeemable convertible preferred stock, ending balance at Mar. 31, 2021   $ 103,565        
Redeemable convertible preferred stock, ending balance, shares at Mar. 31, 2021   11,409,488        
Ending balances, shares at Mar. 31, 2021     2,730,298      
Beginning balance at Dec. 31, 2020 (20,319)         (20,319)
Redeemable convertible preferred stock, Beginning balance at Dec. 31, 2020   $ 23,070        
Redeemable convertible preferred stock, beginning balance, shares at Dec. 31, 2020   6,076,196        
Beginning balance, shares at Dec. 31, 2020     2,707,468      
Net loss (7,055)          
Ending balances at Jun. 30, 2021 (29,842)         (29,842)
Redeemable convertible preferred stock, ending balance at Jun. 30, 2021   $ 105,469        
Redeemable convertible preferred stock, ending balance, shares at Jun. 30, 2021   11,409,488        
Ending balances, shares at Jun. 30, 2021     2,730,298      
Beginning balance at Mar. 31, 2021 (23,114)         (23,114)
Redeemable convertible preferred stock, Beginning balance at Mar. 31, 2021   $ 103,565        
Redeemable convertible preferred stock, beginning balance, shares at Mar. 31, 2021   11,409,488        
Beginning balance, shares at Mar. 31, 2021     2,730,298      
Redeemable convertible preferred stock, Accretion to redemption value and cumulative dividends on preferred stock   $ 1,904        
Accretion to redemption value and cumulative dividends on preferred stock (1,904)     (183)   (1,721)
Vesting of early exercised stock options 4     4    
Stock-based compensation 179     179    
Net loss (5,007)         (5,007)
Ending balances at Jun. 30, 2021 (29,842)         (29,842)
Redeemable convertible preferred stock, ending balance at Jun. 30, 2021   $ 105,469        
Redeemable convertible preferred stock, ending balance, shares at Jun. 30, 2021   11,409,488        
Ending balances, shares at Jun. 30, 2021     2,730,298      
Beginning balance at Dec. 31, 2021 (47,411)       $ (27) (47,384)
Redeemable convertible preferred stock, Beginning balance at Dec. 31, 2021 $ 109,319 $ 109,319        
Redeemable convertible preferred stock, beginning balance, shares at Dec. 31, 2021 11,409,488 11,409,488        
Beginning balance, shares at Dec. 31, 2021     2,730,298      
Redeemable convertible preferred stock, Accretion to redemption value and cumulative dividends on preferred stock   $ 1,820        
Accretion to redemption value and cumulative dividends on preferred stock $ (1,820)     (437)   (1,383)
Redeemable convertible preferred stock, conversion of convertible preferred stock into common stock   $ (111,139)        
Redeemable convertible preferred stock, conversion of convertible preferred stock into common stock, shares   (11,409,488)        
Conversion of convertible preferred stock into common stock 111,139     111,139    
Conversion of convertible preferred stock into common stock, shares     11,409,488      
Issuance of common stock upon initial public offering, net of underwriters' commission and offering costs 60,836     60,836    
Issuance of common stock upon initial public offering, net of underwriters' commission and offering costs, shares     4,600,000      
Vesting of early exercised stock options 14     14    
Repurchase of early exercised stock options (11)     (11)    
Repurchase of early exercised stock options, shares     (27,128)      
Stock-based compensation 449     449    
Unrealized gain on available-for-sale investments (131)       (131)  
Net loss (7,655)         (7,655)
Ending balances at Mar. 31, 2022 115,410     171,990 (158) (56,422)
Ending balances, shares at Mar. 31, 2022     18,712,658      
Beginning balance at Dec. 31, 2021 (47,411)       (27) (47,384)
Redeemable convertible preferred stock, Beginning balance at Dec. 31, 2021 $ 109,319 $ 109,319        
Redeemable convertible preferred stock, beginning balance, shares at Dec. 31, 2021 11,409,488 11,409,488        
Beginning balance, shares at Dec. 31, 2021     2,730,298      
Issuance of common stock upon the exercise of stock options, shares 0          
Net loss $ (17,775)          
Ending balances at Jun. 30, 2022 $ 115,863     182,765 (360) (66,542)
Redeemable convertible preferred stock, ending balance at Jun. 30, 2022          
Redeemable convertible preferred stock, ending balance, shares at Jun. 30, 2022 0 0        
Ending balances, shares at Jun. 30, 2022     19,402,658      
Beginning balance at Mar. 31, 2022 $ 115,410     171,990 (158) (56,422)
Beginning balance, shares at Mar. 31, 2022     18,712,658      
Issuance of common stock upon initial public offering, net of underwriters' commission and offering costs 9,530     9,530    
Issuance of common stock upon initial public offering, net of underwriters' commission and offering costs, shares     690,000      
Vesting of early exercised stock options 3     3    
Stock-based compensation 1,242     1,242    
Unrealized gain on available-for-sale investments (202)       (202)  
Net loss (10,120)         (10,120)
Ending balances at Jun. 30, 2022 $ 115,863     $ 182,765 $ (360) $ (66,542)
Redeemable convertible preferred stock, ending balance at Jun. 30, 2022          
Redeemable convertible preferred stock, ending balance, shares at Jun. 30, 2022 0 0        
Ending balances, shares at Jun. 30, 2022     19,402,658